Barricaid Stock

Barricade is a clinical-stage medical device company focused on developing minimally invasive solutions for chronic disc-related back pain. Its flagship product, the AnulusSEAL™, is designed to treat lumbar disc herniations by sealing tears in the outer layer of the spinal disc (the annulus fibrosis) to contain disc material, alleviate nerve compression, and reduce pain.